JCM
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cassone, M.
Right arrow Articles by Venditti, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cassone, M.
Right arrow Articles by Venditti, M.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, November 2003, p. 5340-5343, Vol. 41, No. 11
0095-1137/03/$08.00+0     DOI: 10.1128/JCM.41.11.5340-5343.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

Outbreak of Saccharomyces cerevisiae Subtype boulardii Fungemia in Patients Neighboring Those Treated with a Probiotic Preparation of the Organism

Marco Cassone,1* Pietro Serra,1 Francesca Mondello,2 Antonietta Girolamo,2 Sandro Scafetti,3 Eleonora Pistella,1 and Mario Venditti1

III Clinica Medica, Dipartimento di Medicina Clinica, Università degli Studi di Roma "La Sapienza,",1 Dipartimento di Malattie infettive, parassitarie ed immunomediate, Istituto Superiore di Sanità,2 Reparto di Rianimazione e Terapia Intensiva, Ospedale "Sandro Pertini," Rome, Italy3

Received 4 February 2003/ Returned for modification 26 April 2003/ Accepted 7 August 2003

We report an outbreak of Saccharomyces cerevisiae subtype boulardii fungemia among three intensive care unit roommates of patients receiving lyophilized preparations of this fungus. The fungemia was probably due to central venous catheter contamination and resolved after fluconazole treatment. The need for stringent application of proper hygiene when using a probiotic preparation of this organism is emphasized.


* Corresponding author. Mailing address: Department of Molecular Biology, University of Siena, Policlinico "Le Scotte," lotto 5, piano 1, Viale Bracci, 53100 Siena, Italy. Phone: 390577233373. Fax: 390577233334. E-mail: mcassone{at}libero.it.


Journal of Clinical Microbiology, November 2003, p. 5340-5343, Vol. 41, No. 11
0095-1137/03/$08.00+0     DOI: 10.1128/JCM.41.11.5340-5343.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Microbiol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 2003 by the American Society for Microbiology. All rights reserved.